The role of supplemental oxygen and JAK/STAT signaling in intravitreous neovascularization in a ROP rat model

Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3360-5. doi: 10.1167/iovs.08-3256. Epub 2009 Mar 5.

Abstract

Purpose: To investigate whether oxygen stresses experienced in retinopathy of prematurity (ROP) trigger signaling through reactive oxygen species (ROS) and whether the Janus kinase-signal transducer and activator of transcription (JAK/STAT) pathway lead to intravitreous neovascularization (IVNV) in an oxygen-induced retinopathy (OIR) rat model.

Methods: Newborn rat pups exposed to repeated fluctuations in oxygen and rescued in supplemental oxygen (28% O(2), 50/10 OIR+SO) were treated with apocynin, an NADPH oxidase and ROS inhibitor (10 mg/kg/d), AG490, a JAK2 inhibitor (5 mg/kg/d), or phosphate-buffered saline. Intraperitoneal injections were given from postnatal day (P)12 to P17 (apocynin), or from P3 to P17 (AG490). Outcomes were intravitreous neovascularization and avascular/total retinal areas, vascular endothelial growth factor, phosphorylated JAK2, and phosphorylated STAT3.

Results: Apocynin significantly reduced phosphorylated STAT3 in 50/10 OIR+SO (P = 0.04), in association with previously reported inhibition of the IVNV area. Inhibition of JAK with AG490 significantly reduced phosphorylated JAK2 (P < 0.001), phosphorylated STAT3 (P = 0.002), and IVNV area (P = 0.033) in the 50/10 OIR+SO model compared with control.

Conclusions: Activation of NADPH oxidase from supplemental oxygen works through activated STAT3 to lead to IVNV. In addition, inhibition of the JAK/STAT pathway reduces IVNV. Further studies are needed to determine the effects and relationships of oxygen stresses on JAK/STAT and NAPDH oxidase signaling.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Acetophenones / pharmacology
  • Animals
  • Animals, Newborn
  • Blotting, Western
  • Disease Models, Animal
  • Enzyme Inhibitors / pharmacology
  • Enzyme-Linked Immunosorbent Assay
  • Humans
  • Hyperoxia / metabolism*
  • Infant, Newborn
  • Janus Kinase 2 / antagonists & inhibitors
  • Janus Kinase 2 / physiology*
  • NADPH Oxidases / metabolism
  • Neovascularization, Pathologic / metabolism*
  • Neovascularization, Pathologic / pathology
  • Phosphorylation
  • RNA, Messenger / metabolism
  • Rats
  • Rats, Sprague-Dawley
  • Reactive Oxygen Species
  • Retinal Vessels / metabolism
  • Retinal Vessels / pathology
  • Retinopathy of Prematurity / metabolism*
  • Retinopathy of Prematurity / pathology
  • Reverse Transcriptase Polymerase Chain Reaction
  • STAT3 Transcription Factor / antagonists & inhibitors
  • STAT3 Transcription Factor / physiology*
  • Signal Transduction / physiology*
  • Tyrphostins / pharmacology
  • Vascular Endothelial Growth Factor A / metabolism
  • Vitreous Body / blood supply*

Substances

  • Acetophenones
  • Enzyme Inhibitors
  • RNA, Messenger
  • Reactive Oxygen Species
  • STAT3 Transcription Factor
  • Stat3 protein, rat
  • Tyrphostins
  • Vascular Endothelial Growth Factor A
  • alpha-cyano-(3,4-dihydroxy)-N-benzylcinnamide
  • vascular endothelial growth factor A, rat
  • acetovanillone
  • NADPH Oxidases
  • Jak2 protein, rat
  • Janus Kinase 2